Royalty Pharma Announces Expansion of Leadership Team
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 57.78 +0.85 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.93 | 52 Week High | $3.48 | |||
| Open | $57.04 | 52 Week Low | $0.80 | |||
| Day High | $57.92 | P/E | N/A | |||
| Day Low | $56.85 | EPS | $-1.54 | |||
| Volume | 2,465,337 | |||||
